Takeda says first patient given Novavax COVID-19 vaccine in Japan clinical trial


Takeda says first patient given Novavax COVID-19 vaccine
TOKYO (Reuters) – Takeda Pharmaceutical Co said on Wednesday the first patient had been given Novavax Inc.#8217;s COVID-19 vaccine candidate in a Japanese clinical trial. Takeda, Japan’s biggest …


Takeda says first patient given Novavax COVID-19 vaccine
Takeda Pharmaceutical Co said on Wednesday the first patient had been given Novavax Inc’s COVID-19 vaccine candidate in a Japanese clinical trial. Takeda, Japan’s biggest drugmaker, is helping bring two Western-developed COVID-19 vaccines to the domestic market. It plans to produce about 250 million doses of the Novavax vaccine in Japan and will import 50 million of the one made by Moderna Inc.


UPDATE 1-Takeda says first patient given Novavax COVID-19
Takeda Pharmaceutical Cosaid on Wednesday the first patient had been given Novavax Inc’sCOVID-19 vaccine candidate in a Japanese clinicaltrial. Takeda, Japan’s biggest drugmaker, is helping bring …


Takeda Doses First Participant In Novavax COVID-19 Vaccine
Takeda Pharmaceutical Co Ltd (NYSE: TAK) said that the first patient had been dosed with Novavax Inc’s (NASDAQ: NVAX) COVID-19 vaccine candidate (dubbed as TAK-019) in a Japanese clinical trial.


Takeda says first patient given Novavax COVID-19 vaccine
Takeda Pharmaceutical Co said on Wednesday the first patient had been given Novavax Inc’s COVID-19 vaccine candidate in a Japanese clinical trial. A dds details from second paragraph.


Takeda says first patient given Novavax COVID-19 vaccine
TOKYO (Reuters) – Takeda Pharmaceutical Co said on Wednesday the first patient had been given Novavax Inc’s COVID-19 vaccine candidate in a Japanese clinical trial. Takeda, Japan’s biggest drugmaker, is helping bring two Western-developed COVID-19 vaccines to the domestic market. It plans to produce about 250 million doses of the Novavax vaccine in Japan and […]


Takeda says first patient given Novavax COVID-19 vaccine
TOKYO – Takeda Pharmaceutical Co said on Wednesday the first patient had been given Novavax Inc’s COVID-19 vaccine candidate in a Japanese clinical trial.


Takeda says first subject given Novavax COVID-19 vaccine
TOKYO (Reuters) – Takeda Pharmaceutical Co said on Wednesday the first patient had been given Novavax Inc’s COVID-19 vaccine candidate in a Japanese clinical trial. Takeda, Japan’s biggest drugmaker, is helping bring two Western-developed COVID-19 vaccines to the domestic market.


UPDATE 1-Takeda says first patient given Novavax COVID-19
Adds details from second paragraph. TOKYO, Feb 24 (Reuters) – Takeda Pharmaceutical Co 4502.T said on Wednesday the first patient had been given Novavax Inc’s NVAX.O COVID-19 vaccine candidate in a Japanese clinical trial. T akeda, Japan’s biggest drugmaker, is helping bring two Western-developed COVID-19 vaccines to the domestic market. It plans to produce about 250 million doses of the …


Takeda says first patient given Novavax COVID-19 vaccine
Takeda Pharmaceutical Co (TAK) said on Wednesday the first patient had been given Novavax Inc’s COVID-19 vaccine candidate… Takeda says first patient given Novavax COVID-19 vaccine in Japan clinical trial
TPMS Programming Tool